Celogics
Pre-clinicalCelogics strives to provide quality human cardiomyocytes derived from human induced pluripotent stem (iPS) cells using optimized proprietary protocols.
Founded
2005
Focus
Cell & Gene Therapy
About
Celogics strives to provide quality human cardiomyocytes derived from human induced pluripotent stem (iPS) cells using optimized proprietary protocols.
Funding History
1Total raised: $1.8M
Seed$1.8MUndisclosedMay 15, 2019
Company Info
TypePrivate
Founded2005
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile